The Pennant Group, Inc. (PNTG)
USD 25.12
(2.51%)
USD 25.12
(2.51%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 394.17 Million USD | 2.0% |
| 2022 | 386.46 Million USD | -7.11% |
| 2021 | 416.05 Million USD | 2.53% |
| 2020 | 405.8 Million USD | 7.74% |
| 2019 | 376.63 Million USD | 1046.09% |
| 2018 | 32.86 Million USD | 15.82% |
| 2017 | 28.37 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 429.47 Million USD | 3.73% |
| 2024 Q1 | 414.01 Million USD | 5.03% |
| 2023 Q3 | 380.79 Million USD | -0.24% |
| 2023 Q4 | 394.17 Million USD | 3.51% |
| 2023 FY | 394.17 Million USD | 2.0% |
| 2023 Q1 | 378.93 Million USD | -1.95% |
| 2023 Q2 | 381.71 Million USD | 0.73% |
| 2022 Q4 | 386.46 Million USD | 0.63% |
| 2022 Q1 | 389.5 Million USD | -6.38% |
| 2022 FY | 386.46 Million USD | -7.11% |
| 2022 Q3 | 384.04 Million USD | 1.48% |
| 2022 Q2 | 378.44 Million USD | -2.84% |
| 2021 Q2 | 419.82 Million USD | 1.26% |
| 2021 FY | 416.05 Million USD | 2.53% |
| 2021 Q4 | 416.05 Million USD | 0.17% |
| 2021 Q3 | 415.35 Million USD | -1.07% |
| 2021 Q1 | 414.6 Million USD | 2.17% |
| 2020 Q1 | 382.8 Million USD | 1.64% |
| 2020 Q2 | 386.74 Million USD | 1.03% |
| 2020 FY | 405.8 Million USD | 7.74% |
| 2020 Q4 | 405.8 Million USD | 3.85% |
| 2020 Q3 | 390.77 Million USD | 1.04% |
| 2019 Q1 | 266.92 Million USD | 712.25% |
| 2019 FY | 376.63 Million USD | 1046.09% |
| 2019 Q4 | 376.63 Million USD | 35.15% |
| 2019 Q3 | 278.67 Million USD | 3.14% |
| 2019 Q2 | 270.17 Million USD | 1.22% |
| 2018 Q4 | 32.86 Million USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | 32.86 Million USD | 15.82% |
| 2017 FY | 28.37 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.47 Billion USD | 84.049% |
| Addus HomeCare Corporation | 317.73 Million USD | -24.059% |
| AirSculpt Technologies, Inc. | 129.56 Million USD | -204.242% |
| Amedisys, Inc. | 940.38 Million USD | 58.084% |
| American Oncology Network, Inc. | 368.72 Million USD | -6.902% |
| Astrana Health, Inc. | 522.59 Million USD | 24.573% |
| Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | 77.662% |
| IMAC Holdings, Inc. | 1.89 Million USD | -20681.478% |
| biote Corp. | 191.84 Million USD | -105.47% |
| Cryo-Cell International, Inc. | 72.25 Million USD | -445.557% |
| Cross Country Healthcare, Inc. | 205.92 Million USD | -91.418% |
| COMPASS Pathways plc | 50.24 Million USD | -684.539% |
| DocGo Inc. | 185.28 Million USD | -112.745% |
| The Ensign Group, Inc. | 2.68 Billion USD | 85.293% |
| Healthcare Services Group, Inc. | 346.56 Million USD | -13.738% |
| InnovAge Holding Corp. | 247.85 Million USD | -59.036% |
| Assure Holdings Corp. | 22.84 Million USD | -1625.135% |
| The Joint Corp. | 62.37 Million USD | -531.905% |
| LifeStance Health Group, Inc. | 804.27 Million USD | 50.99% |
| Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | -10242.672% |
| ModivCare Inc. | 1.61 Billion USD | 75.533% |
| NewGenIvf Group Limited | 1.24 Million USD | -31651.642% |
| Novo Integrated Sciences, Inc. | 11.06 Million USD | -3462.699% |
| Option Care Health, Inc. | 1.9 Billion USD | 79.327% |
| P3 Health Partners Inc. | 427.3 Million USD | 7.753% |
| P3 Health Partners Inc. | 427.3 Million USD | 7.753% |
| Surgery Partners, Inc. | 3.65 Billion USD | 89.222% |
| Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -43212.617% |
| Talkspace, Inc. | 23.57 Million USD | -1572.008% |
| Talkspace, Inc. | 23.57 Million USD | -1572.008% |
| The Oncology Institute, Inc. | 162.39 Million USD | -142.73% |
| The Oncology Institute, Inc. | 162.39 Million USD | -142.73% |